SANDS FRANK M.

Sociétés où SANDS FRANK M. a négocié

• Inhibikase Therapeutics, Inc.1 tx · $3M · Nov 24, 2025
• Acumen Pharmaceuticals, Inc.5 tx · $6.7M · Jul 8, 2021

Historique de performance de SANDS FRANK M.

Historique insuffisant pour un historique de performance statistique (moins de 5 achats sur le marché).

Historique des transactions de SANDS FRANK M.

Co-initiés de SANDS FRANK M.

• Kolchinsky PeterAcumen Pharmaceuticals, Inc. +1
• RA Capital Biotech Fund LPAcumen Pharmaceuticals, Inc. +1
• RA CAPITAL MANAGEMENT, LLCAcumen Pharmaceuticals, Inc. +1
• Shah Rajeev M.Acumen Pharmaceuticals, Inc. +1
• Barton RussellAcumen Pharmaceuticals, Inc.
• Bellini RobertoInhibikase Therapeutics, Inc.
• BERMAN DENNIS NInhibikase Therapeutics, Inc.
• Cabell ChristopherInhibikase Therapeutics, Inc.
• Canner DavidInhibikase Therapeutics, Inc.
• Dion GiseleInhibikase Therapeutics, Inc.
• Doherty James J.Acumen Pharmaceuticals, Inc.
• Drapkin Kimberlee CAcumen Pharmaceuticals, Inc.
• Fountain Nathan BAcumen Pharmaceuticals, Inc.
• FRATTAROLI JOSEPHInhibikase Therapeutics, Inc.
• Freeman Roy LesterInhibikase Therapeutics, Inc.
• Golumbeski GeorgeAcumen Pharmaceuticals, Inc.
• GRINT PAUL CInhibikase Therapeutics, Inc.
• Hardie Robert D.Acumen Pharmaceuticals, Inc.
• Ives Jeffrey L.Acumen Pharmaceuticals, Inc.
• Iwicki Mark TInhibikase Therapeutics, Inc.
• Kalman DanielInhibikase Therapeutics, Inc.
• Kush ArvindInhibikase Therapeutics, Inc.
• Lees-Rolfe GarthInhibikase Therapeutics, Inc.
• Manning Paul BAcumen Pharmaceuticals, Inc.